We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.09%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$269B
AUM Growth
+$11B
(+4.3%)
Cap. Flow
-$7.32B
Cap. Flow
% of AUM
-2.72%
Top 10 Holdings %
Top 10 Hldgs %
22.8%
Holding
3,195
New
25
Increased
1,065
Reduced
1,860
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$425M |
| 3 |
Boeing
BA
|
+$396M |
| 4 |
Linde
LIN
|
+$381M |
| 5 |
ExxonMobil
XOM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.4B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$323M |
| 3 |
Accenture
ACN
|
+$264M |
| 4 |
Microsoft
MSFT
|
+$258M |
| 5 |
Union Pacific
UNP
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
City Holding Co
CHCO
$2.04B
| $3.48M | ﹤0.01% |
38,344
-5,042
| -12% | -$477K |
|
|
CERE
2052
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $3.48M | ﹤0.01% |
142,906
-3,062
| -2% | -$89.9K |
|
2053
Compass
COMP
$9.66B
| $3.48M | ﹤0.01% |
1,078,462
-41,048
| -4% | -$141K |
|
2054
Anika Therapeutics
ANIK
$287M
| $3.48M | ﹤0.01% |
121,212
+51,420
| +74% | +$1.53M |
|
2055
US Physical Therapy
USPH
$1.22B
| $3.48M | ﹤0.01% |
35,548
-347
| -1% | -$33.1K |
|
2056
Tennant Co
TNC
$1.26B
| $3.48M | ﹤0.01% |
50,721
-3,270
| -6% | -$222K |
|
|
TWO
2057
Two Harbors Investment
TWO
$1.27B
| $3.47M | ﹤0.01% |
236,063
-13,579
| -5% | -$221K |
|
2058
Lennar Class B
LEN.B
$20.8B
| $3.46M | ﹤0.01% |
40,809
+2,524
| +7% | +$201K |
|
|
ARI
2059
Apollo Commercial Real Estate
ARI
$885M
| $3.45M | ﹤0.01% |
370,266
-41,538
| -10% | -$460K |
|
|
HT
2060
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $3.44M | ﹤0.01% |
511,969
+234,262
| +84% | +$1.9M |
|
2061
Enviri
NVRI
$620M
| $3.44M | ﹤0.01% |
503,107
+88,907
| +21% | +$670K |
|
2062
Arvinas
ARVN
$572M
| $3.43M | ﹤0.01% |
125,694
-9,572
| -7% | -$302K |
|
2063
AdaptHealth
AHCO
$759M
| $3.43M | ﹤0.01% |
276,116
-122,810
| -31% | -$2.26M |
|
2064
Marten Transport
MRTN
$1.22B
| $3.42M | ﹤0.01% |
163,271
-24,423
| -13% | -$519K |
|
2065
Genesco
GCO
$422M
| $3.41M | ﹤0.01% |
92,423
-46,171
| -33% | -$2.02M |
|
|
CLDT
2066
Chatham Lodging
CLDT
$586M
| $3.4M | ﹤0.01% |
324,437
+45,610
| +16% | +$558K |
|
|
PMT
2067
PennyMac Mortgage Investment
PMT
$842M
| $3.4M | ﹤0.01% |
275,950
-1,753
| -0.6% | -$23.6K |
|
2068
IDT Corp
IDT
$1.62B
| $3.4M | ﹤0.01% |
99,738
+50,252
| +102% | +$1.55M |
|
2069
Safe Bulkers
SB
$774M
| $3.4M | ﹤0.01% |
920,991
-210,668
| -19% | -$708K |
|
2070
Kymera Therapeutics
KYMR
$8.94B
| $3.39M | ﹤0.01% |
114,401
-9,384
| -8% | -$303K |
|
2071
MINISO
MNSO
$3.75B
| $3.39M | ﹤0.01% |
+190,900
| New | +$3.08M |
|
2072
Compañía de Minas Buenaventura
BVN
$8.67B
| $3.38M | ﹤0.01% |
413,344
-44,000
| -10% | -$351K |
|
2073
Community Trust Bancorp
CTBI
$1.41B
| $3.38M | ﹤0.01% |
88,937
+25,068
| +39% | +$1.06M |
|
2074
Mesa Laboratories
MLAB
$574M
| $3.37M | ﹤0.01% |
19,302
+271
| +1% | +$48.6K |
|
2075
Ubiquiti
UI
$34.3B
| $3.37M | ﹤0.01% |
12,400
-1,185
| -9% | -$328K |
|
Similar funds
VFT
Nuveen's Q1 2023 Portfolio in Review
As of Q1 2023, Nuveen held 3,195 positions worth $269B, up 4.3% from $258B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.3%. Nuveen opened 25 new positions and exited 81, leaving the 3,195-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q1 2023 buy was GE HealthCare: 1,240,905 shares worth $102M.
- Nuveen added most to Meta Platforms (Facebook) in Q1 2023, an estimated $1.08B increase.
- Nuveen's biggest Q1 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.4B.
- Nuveen fully exited SVB Financial Group in Q1 2023, selling an estimated $51.6M.
- Nuveen's ten largest holdings make up 23% of its $269B portfolio in Q1 2023.
- Nuveen opened 25 new positions and closed 81 in Q1 2023.
- Nuveen's portfolio value rose 4.3% quarter-over-quarter to $269B.
Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.